医学
糖尿病
氧化应激
2型糖尿病
健康衰老
生物信息学
衰老
2型糖尿病
炎症
生物
老年学
免疫学
内科学
内分泌学
作者
Wei Peng,Rui Zhou,Zefang Sun,Jia-Wei Long,Yong-Qiang Gong
出处
期刊:Aging and Disease
[Buck Institute for Research on Aging]
日期:2022-01-01
卷期号:13 (2): 468-468
被引量:71
标识
DOI:10.14336/ad.2021.0928
摘要
Aging and aging-related diseases have emerged as increasingly severe health and social problems. Therefore, it is imperative to discover novel and effective therapeutics to delay the aging process and to manage aging-related diseases. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), one of the classes of antihyperglycemic drugs, have been recommended to manage type 2 diabetes mellitus (T2DM). Moreover, GLP-1 RAs have been shown to protect against oxidative stress, cellular senescence and chronic inflammation, which are widely accepted as the major risk factors of aging. However, their significance in aging or aging-related diseases has not been elucidated. Herein, we explain the underlying mechanisms and protective roles of GLP-1 RAs in aging from a molecular, cellular and phenotypic perspective. We provide novel insights into the broad prospect of GLP-1 RAs in preventing and treating aging-related diseases. Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases. This review forms a basis for further studies on the relationship between aging-related diseases and GLP-1 RAs.
科研通智能强力驱动
Strongly Powered by AbleSci AI